Authors: Mara Therese P. Evangelista MD, DPDS and Nick Huber
During the course of a clinical trial, large amounts of data
are usually collected at different time points (i.e. at baseline and during follow-up visits). This results in the possibility of multiple statistical tests and various ways that the results can be reported. Some authors would naturally hope to show ‘interesting’ data, and this can lead to a tendency to hype
the results. This must be resisted. It is of the utmost importance to report a balanced view of the results. This is why it is essential, before a trial starts, to have a protocol that states the primary and secondary endpoints and includes a pre-specified analysis plan.
Evangelista MT, Huber N. Writing result in a clinical trial report. J Phil Dermatol Soc. 2018; 27(1): 11-4.
Clinical Trial, Report, Tests,Research
Authors: Katrina Carmela M. Belen, MD, DPDS, Jasmin J.Jamora, MD, FPDS , Ma. Cecilia P. Ingente MD, DPDSAbstractBackground: Dermoscopy, a non-invasive diagnostic tool, has been proven to improve the diagnostic accuracy of vascular tumors since it can aid in...
A randomized, double-blind, comparative study on the safety and efficacy of virgin coconut (Cocos nucifera l.) oil against 1% hydrocortisone lotion as an anti-inflammatory and antipruritic preparation for mosquito reactions
Authors: Uy, Veronica S, MD; Gracia B. Teodosio, MD, FPDS; Ma. Teresita G. Gabriel, MD, FPDS; Mary Catherine T. Galang, MD; Mohammad Yoga A. Waskito, MD; Johannes F. Dayrit, MD, FPDS Abstract Background: Virgin coconut oil (VCO) has been reported...
Primary Cutaneous Anaplastic Large Cell Lymphoma (PC-ALCL) is a rare Non-Hodgkin lymphoma (NHL) representing approximately 9% of all cutaneous lymphomas.3 It usually manifests as a slow-growing, solitary tumor which has a tendency to regress spontaneously. However, metastasis is reported in 5-10% of cases.